Apogee Therapeutics stock hits all-time high at 134.89 USD
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
Colombia Peso Stumbles as Dollar Shortage Tests Carry Appeal
The Colombian peso’s stunning rally lost momentum this week as the local financial system ran short of dollars, exposing the limits of the currency’s carry appeal.
U.S. Treasury Secretary Scott Bessent's Plan to Calm the Bond Market Could Have Unintended Consequences for Fed Chair Kevin Warsh
Bessent recently announced the U.S. Treasury Department would expand repurchases of longer-dated bonds.
Microsoft Earns 31% More Than It Did a Year Ago and Is Worth Less
The software giant increased its fiscal 2026 net income by 31%. The market cut what it pays for each dollar of those earnings by about a quarter.
Promoters cash in on rally, offload shares worth ₹13,000 crore in August block deals
The biggest deal was in Groww’s parent, Billionbrains Garage Ventures, where 12.74 crore shares (2.1% of equity) were traded for about ₹2,500 crore at approximately ₹196.2 per share